AGIOS PHARMACEUTICALS, INC. Insider Trading for September 2014
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in AGIOS PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in AGIOS PHARMACEUTICALS, INC. for September 2014.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 29 2014 | AGIO | AGIOS PHARMACEUTIC ... | Goddard Glenn | Senior Vice Preside ... | Option Exercise | M | 9.05 | 7,548 | 68,309 | 111,998 | |
| Sep 29 2014 | AGIO | AGIOS PHARMACEUTIC ... | Goddard Glenn | Senior Vice Preside ... | Option Exercise | M | 2.34 | 9,725 | 22,757 | 119,546 | |
| Sep 29 2014 | AGIO | AGIOS PHARMACEUTIC ... | Goddard Glenn | Senior Vice Preside ... | Option Exercise | M | 0.69 | 227 | 156 | 129,271 | |
| Sep 29 2014 | AGIO | AGIOS PHARMACEUTIC ... | Goddard Glenn | Senior Vice Preside ... | Sell | S | 56.53 | 17,500 | 989,275 | 0 | 17.5 K to 0 (-100.00 %) |
| Sep 29 2014 | AGIO | AGIOS PHARMACEUTIC ... | Goddard Glenn | Senior Vice Preside ... | Buy | M | 9.05 | 7,548 | 68,309 | 17,500 | 10 K to 17.5 K (+75.84 %) |
| Sep 29 2014 | AGIO | AGIOS PHARMACEUTIC ... | Goddard Glenn | Senior Vice Preside ... | Buy | M | 2.34 | 9,725 | 22,757 | 9,952 | 227 to 10 K (+4,284.14 %) |
| Sep 29 2014 | AGIO | AGIOS PHARMACEUTIC ... | Goddard Glenn | Senior Vice Preside ... | Buy | M | 0.69 | 227 | 156 | 227 | 0 to 227 |
| Sep 29 2014 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Option Exercise | M | 0.30 | 30,000 | 9,075 | 780,820 | |
| Sep 29 2014 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Sell | S | 62.68 | 30,000 | 1,880,400 | 137,772 | 167.8 K to 137.8 K (-17.88 %) |
| Sep 29 2014 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Sell | S | 62.68 | 30,000 | 1,880,400 | 253,272 | 283.3 K to 253.3 K (-10.59 %) |
| Sep 29 2014 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Buy | M | 0.30 | 30,000 | 9,075 | 283,272 | 253.3 K to 283.3 K (+11.84 %) |
| Sep 26 2014 | AGIO | AGIOS PHARMACEUTIC ... | Goddard Glenn | Senior Vice Preside ... | Option Exercise | A | 0.00 | 10,000 | 0 | 10,000 | |
| Sep 22 2014 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Option Exercise | M | 0.47 | 37,996 | 17,763 | 265,817 | |
| Sep 22 2014 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Sell | S | 50.45 | 37,996 | 1,916,898 | 35,000 | 73 K to 35 K (-52.05 %) |
| Sep 22 2014 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Buy | M | 0.47 | 37,996 | 17,763 | 72,996 | 35 K to 73 K (+108.56 %) |
| Sep 12 2014 | AGIO | AGIOS PHARMACEUTIC ... | STARR KEVIN P | Director | Buy | J | 0.00 | 8,772 | 0 | 26,519 | 17.7 K to 26.5 K (+49.43 %) |
| Sep 12 2014 | AGIO | AGIOS PHARMACEUTIC ... | STARR KEVIN P | Director | Sell | J | 0.00 | 60,567 | 0 | 0 | 60.6 K to 0 (-100.00 %) |
| Sep 12 2014 | AGIO | AGIOS PHARMACEUTIC ... | STARR KEVIN P | Director | Buy | J | 0.00 | 60,567 | 0 | 60,567 | 0 to 60.6 K |
| Sep 12 2014 | AGIO | AGIOS PHARMACEUTIC ... | STARR KEVIN P | Director | Sell | J | 0.00 | 825,000 | 0 | 3,070,090 | 3.9 M to 3.1 M (-21.18 %) |
| Sep 12 2014 | AGIO | AGIOS PHARMACEUTIC ... | THIRD ROCK VENTURES LP | 10% Owner | Sell | J | 0.00 | 60,567 | 0 | 0 | 60.6 K to 0 (-100.00 %) |
| Sep 12 2014 | AGIO | AGIOS PHARMACEUTIC ... | THIRD ROCK VENTURES LP | 10% Owner | Buy | J | 0.00 | 60,567 | 0 | 60,567 | 0 to 60.6 K |
| Sep 12 2014 | AGIO | AGIOS PHARMACEUTIC ... | THIRD ROCK VENTURES LP | 10% Owner | Sell | J | 0.00 | 825,000 | 0 | 3,070,090 | 3.9 M to 3.1 M (-21.18 %) |
| Sep 03 2014 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Option Exercise | M | 0.47 | 4,500 | 2,104 | 303,813 | |
| Sep 03 2014 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Option Exercise | M | 0.47 | 5,000 | 2,338 | 308,313 | |
| Sep 03 2014 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Sell | S | 46.30 | 4,500 | 208,350 | 35,000 | 39.5 K to 35 K (-11.39 %) |
| Sep 03 2014 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Buy | M | 0.47 | 4,500 | 2,104 | 39,500 | 35 K to 39.5 K (+12.86 %) |
| Sep 03 2014 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Buy | M | 0.47 | 5,000 | 2,338 | 35,000 | 30 K to 35 K (+16.67 %) |
| Sep 03 2014 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Option Exercise | M | 0.30 | 6,500 | 1,966 | 810,820 | |
| Sep 03 2014 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Sell | S | 46.30 | 6,500 | 300,950 | 167,772 | 174.3 K to 167.8 K (-3.73 %) |
| Sep 03 2014 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Sell | S | 46.30 | 6,500 | 300,950 | 253,272 | 259.8 K to 253.3 K (-2.50 %) |
| Sep 03 2014 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Buy | M | 0.30 | 6,500 | 1,966 | 259,772 | 253.3 K to 259.8 K (+2.57 %) |
| Sep 03 2014 | AGIO | AGIOS PHARMACEUTIC ... | Goddard Glenn | Senior Vice Preside ... | Option Exercise | M | 2.34 | 9,545 | 22,335 | 129,498 | |
| Sep 03 2014 | AGIO | AGIOS PHARMACEUTIC ... | Goddard Glenn | Senior Vice Preside ... | Option Exercise | M | 0.69 | 455 | 313 | 139,043 | |
| Sep 03 2014 | AGIO | AGIOS PHARMACEUTIC ... | Goddard Glenn | Senior Vice Preside ... | Sell | S | 46.30 | 10,000 | 463,000 | 0 | 10 K to 0 (-100.00 %) |
| Sep 03 2014 | AGIO | AGIOS PHARMACEUTIC ... | Goddard Glenn | Senior Vice Preside ... | Buy | M | 2.34 | 9,545 | 22,335 | 10,000 | 455 to 10 K (+2,097.80 %) |
| Sep 03 2014 | AGIO | AGIOS PHARMACEUTIC ... | Goddard Glenn | Senior Vice Preside ... | Buy | M | 0.69 | 455 | 313 | 455 | 0 to 455 |
| Sep 03 2014 | AGIO | AGIOS PHARMACEUTIC ... | Higgons John Duncan | Chief Operating Off ... | Option Exercise | M | 0.30 | 6,745 | 2,040 | 297,022 | |
| Sep 03 2014 | AGIO | AGIOS PHARMACEUTIC ... | Higgons John Duncan | Chief Operating Off ... | Sell | S | 46.30 | 13,000 | 601,900 | 169,835 | 182.8 K to 169.8 K (-7.11 %) |
| Sep 03 2014 | AGIO | AGIOS PHARMACEUTIC ... | Higgons John Duncan | Chief Operating Off ... | Buy | M | 0.30 | 6,745 | 2,040 | 182,835 | 176.1 K to 182.8 K (+3.83 %) |